Matrix Restructuring During Liver Regeneration is Regulated by Glycosylation of the Matrix Glycoprotein Vitronectin by Haruko Ogawa et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
5 
Matrix Restructuring During Liver  
Regeneration is Regulated by Glycosylation  
of the Matrix Glycoprotein Vitronectin  
Haruko Ogawa1, Kotone Sano2,  
Naomi Sobukawa1 and Kimie Asanuma-Date1 
1Graduate School of Advanced Sciences and Humanities, 
 and Glycoscience Institute, Ochanomizu University, 
2Faculty of World Heritage, Department of Liberal Arts, Cyber University, Tokyo,  
Japan 
1. Introduction  
There are three major approaches for regenerative medicine. The most innovative approach 
among them is: induction of target cells from various stem cells such as induced pluripotent 
stem cells (iPS cells) or embryonic stem cells (ES cells) and implantation of them to 
regenerate the organ. The second approach is: in vitro tissue regeneration that involves 
preparation of artificial tissue by combining human cells with scaffolding biomaterials and 
growth factors. The third is: promotion of self-regeneration through controlling the repair 
activity of each tissue, which most organisms do naturally, is a more fundamental approach, 
but it will also be important in cell therapy to regulate tissue organization after induction of 
differentiation. 
Because tissue homeostasis depends on spatially and temporally controlled expression of 
multifunctional adhesive glycoproteins and receptors, many studies have examined the 
changes of expression of extracellular matrix (ECM) molecules during tissue remodeling, 
inflammation and invasion by cancer cells (DeClerck, Y.A., et al. 2004; Seiffert, D. 1997; Kato, 
S., et al. 1992; Hughes, R.C. 1997) on the one hand. On the other hand, there is increasing 
evidence that glycosylations post-translationally modulate various biological phenomena by 
altering the activity and specificity or the stability of glycoproteins through the biosignaling 
functions of oligosaccharides (Varki, A. 1993; Varki, A., et al., 2009). During tissue 
remodeling, the glycosylated ECM molecules are different from those of normal tissue 
owing to the changes in the expression of many proteins that are responsible for glycan 
synthesis (Dalziel, M., et al. 1999). However, the glycan modulation of most glycoproteins 
that are involved in tissue remodeling has remained unknown.  
When the three big lobes of a liver are excised, the remaining liver recovers its former mass 
and function within about two weeks in humans or 7 to 10 days in rats (Diehl, A.M. and Rai, 
R.M. 1996). ECM degradation occurs in the early stage of this process, followed by 
biosynthesis of the matrix, cell proliferation, and cell differentiation. During this process, 
many glycosyl transferases (Bauer, C.H., et al. 1976; Serafini-Cessi, F. 1977; Okamoto, Y., et 
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al. 1978; Ip, C. 1979; Oda-Tamai, S., et al. 1985; Miyoshi, E., et al. 1995) and total 
glycoconjugates in the liver have been reported to change (Okamoto, Y. and Akamatsu, N. 
1977; Kato, S. and Akamatsu, N. 1984; Kato, S. and Akamatsu, N. 1985; Ishii, I., et al. 1985). 
However, the nature of the links between such glycans changes, and the process of tissue 
remodeling has remained unclear. We consider it important to identify which molecules 
play important roles in the tissue remodeling during liver regeneration, and we will discuss 
the glycan modulation of one extracellular molecule, vitronectin, in this chapter. Vitronectin 
is a multifunctional adhesive glycoprotein that plays a central role in tissue remodeling by 
connecting pericellular tissue lysis with cell adhesion and motility. 
We found that the glycans of vitronectin drastically change during liver regeneration after 
partial hepatectomy. In our studies to determine the glycan structures during the initial 
stage of the liver regeneration after partial hepatectomy of rats, we found that alterations in 
glycosylation, especially decreased sialylation of vitronectin, modulate the biological 
activities of vitronectin during tissue-remodeling processes by multiple steps (Uchibori-
Iwaki, H., et al. 2000; Sano, K., et al. 2010). Liver regeneration is a normal repair process, 
while fibrosis and cirrhosis are considered to be excessive and abnormal repair processes 
that often give rise to cancer. In this context, elucidating how alterations of glycans occur 
and understanding how glycans modulate the glycans on vitronectin is useful in order to 
develop a strategy to regulate matrix remodeling in regeneration and deposition in liver 
cirrhosis. Therefore, we aimed to elucidate glycan modulation during liver regeneration 
after partial hepatectomy. We focused on the changes in vitronectin during liver 
regeneration, especially the changes of the glycan moiety, which plays a crucial role in 
controlling survival of hepatic stellate cells. 
1.1 Structure and function of vitronectin 
Vitronectin is a multifunctional adhesive glycoprotein that originates mainly in hepatocytes 
and circulates in the blood at high concentrations (0.2 mg/ml in human and no more than 
0.1 mg/ml in rats). Vitronectin was first isolated from human serum by Holmes in 1967 as 
an ‘α-1 protein’ (Holmes, R. 1967), and has been referred to as ‘serum spreading factor’, 
‘epibolin’, or ‘S-protein’. It induces cell growth in vitro and is known as a major cell-
adhesive component in cell culture mediums (Hayman, E.G., et al. 1983). Vitronectin is 
present as an ECM component in the liver, as well as various other organs, including 
skeletal muscle, kidney, and brain (Seiffert, D. 1997; Seiffert, D., et al. 1991). Most vitronectin 
in normal plasma is present as an inactive monomer form that does not bind to various 
ligands in the plasma (Gebb, C., et al. 1986; Izumi, M., et al. 1989). In vivo, vitronectin is 
activated in the presence of certain ligands such as heparin, type-1 plasminogen activator 
inhibitor (PAI-1), thrombin-AT-III, membrane attack complex of complements, and through 
a partial conformational change and multimerization process (Preissner, K.T. and Muller-
Berghaus, G. 1987). Tissue vitronectin is considered to be present as an active multimeric 
form. Conformation-dependent binding of vitronectin was also observed for sulfatide 
(Gal(3-SO4)ǃ1-1ceramide), cholesterol 3-sulfate, and various phospholipids including 
phosphatidylserine, but not gangliosides, while vitronectin bound to cholesterol 3-sulfate 
regardless of its conformational state (Yoneda, A., et al. 1998). The binding of vitronectin to 
the membrane lipids and ǃ-endorphin-binding activities were found to be attributable to 
hemopexin domain 2 and hemopexin domain 1, as well as type I collagen and heparin 
(Yoneda, A., et al. 1998). 
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The ligand-binding sites on the domain structure of vitronectins are shown in Fig. 1. 
Vitronectin regulates the proteolytic degradation of matrix and fibrinolysis through binding 
with urokinase-type plasminogen activator, PAI-1, and urokinase receptor (Seiffert, D. 1997; 
Schvartz, I., et al. 1999; Preissner, K.T. 1991; Pretzlaff, R.K., et al. 2000). Besides this function, 
vitronectin plays a key role in cell adhesion and cellular motility during tissue remodeling 
through binding to major ECM receptors, integrins such as ǂvǃ1, ǂvǃ3, ǂvǃ5, ǂvǃ6, ǂvǃ8, 
and other ECM components like collagen and proteoglycans (Schvartz, I., et al. 1999). In 
plasma, vitronectin has been shown to regulate coagulation and thrombolytic and 
complement systems (Preissner, K.T. 1991). By providing a link between plasmin-regulated 
matrix proteolysis and integrin-mediated cell migration, activated vitronectin is considered 
to play a central role in matrix remodeling.  
Fig. 1 also shows the glycosylation structures of vitronectins and ligand-binding sites. N-
glycosylation sites of vitronectins are well conserved among mammals, and vitronectin 
contains almost fully sialylated complex-type N-linked glycans at these sites. Most 
vitronectins, except normal human, additionally contain various amounts of O-linked 
glycans, which differ by species: bovine, rabbit, and especially chicken vitronectins possess 
more O-glycans than N-glycans. Human vitronectin does not contain O-glycans in the 
normal state, while rat vitronectin contain several O-glycans in the connecting region (Sano, 
K., et al. 2010).  
 
 
 
 
Fig. 1. Glycosylation and domain structure models of vitronectins. Human, rat/mouse, and 
porcine vitronectin contain three, four, and two N-glycosylation sites, respectively (Ogawa, 
H., Yoneda, A., et al. 1995) (Yoneda, A., Ogawa, H., et al. 1993) (Sano, K., Miyamoto, Y., et al. 
2010). The numbers of O-glycosylation sites differ by animal species. The major ligand-
binding sites that have been identified are indicated at the top of the figure (Yoneda, A., 
Ogawa, H., et al. 1998) (Preissner, K.T. 1991) (Preissner, K.T. and Seiffert, D. 1998).  
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2. Modulation of vitronectin activities by glycosylation 
De-N-glycosylation of plasma vitronectin by enzyme treatment significantly attenuated the 
cholesterol sulfate-binding activity while it increased the collagen-binding activity. De-O-
glycosylation or desialylation of vitronectin contributed to the stability for proteolysis 
(Uchibori, H., Ogawa, H., et al. 1992). These findings suggest that glycosylations modulate 
the ligand binding activities and the half-life of vitronectin in vivo. We prepared various 
recombinant domains of human vitronectin and mutants with certain domains deleted and 
expressed them separately in E. coli as fusion proteins. Using these recombinants, sulfatide-, 
phosphatidylserine-, cholesterol 3-sulfate-, type I collagen-, heparin-, and beta-endorphin-
binding activities were found to be attributable to hemopexin domains 2 and 1. The 
possibility was suggested that the presence of a somatomedin B domain and/or connecting 
region flanking hemopexin domain 1 inactivated its heparin binding. Further, it was 
indicated that some of the ligand binding activities were modulated by glycosylation of 
plasma vitronectin, which enables modulation of its biological activities by a change in 
glycosylation accompanying the physiological or pathological state of the liver.  
2.1 Changes in vitronectin during liver regeneration 
2.1.1 Changes in collagen-binding activity of plasma vitronectin during early stage of 
liver regeneration  
In this study, we used the liver regeneration of rats induced by two-thirds partial 
hepatectomy as a model system to study whether and how vitronectin plays a role in tissue 
remodeling after hepatectomy and how glycosylations are involved in the physiological 
processes. Vitronectin was purified from plasma at different times during the liver 
regeneration process and analyzed by SDS-PAGE (Uchibori-Iwaki, H., et al. 2000). As shown 
in Fig. 2A, each vitronectin showed one band on SDS-PAGE, and 24 h after partial 
hepatectomy (PH-VN) plasma vitronectin had shifted to a low migration position compared 
to vitronectins purified from plasma of non-operated (NO-VN) or partially hepatectomized 
rats and sham-operated rats (SH-VN), suggesting that the molecular mass of vitronectin had 
shrunk to 65 kDa at 24 h after partial hepatectomy from the 68-69 kDa of other vitronectins. 
At 24 h after operation, the yield of PH-VN had decreased to 1/3 that of sham-operated rats, 
and it was restored by 240 h, when liver regeneration was completed. At this time point, the 
amino acid composition did not change significantly, and the composition divergence 
(Black, J.A. and Harkins, R.N. 1977) of PH-VN was 0.040 when taking that of SH-VN as 0.0. 
All three vitronectins had the same N-terminal sequence, indicating that the three 
vitronectins had high homology among the primary sequence (Uchibori-Iwaki, H., et al. 
2000). 
As shown in Fig. 2B, the purified vitronectins bound to type I collagen by ELISA in a 
concentration-dependent manner, and PH-VN was found to exhibit much greater binding to 
collagen, about 3 times higher than that of SH-VN and NO-VN (Uchibori-Iwaki, H., et al. 
2000). The enhanced binding of PH-VN to immobilized collagen shown by ELISA was 
supported by surface plasmon resonance (SPR), as shown in Fig. 2C. The relative affinity per 
monomer of PH-VN is remarkably high compared with those of NO- and SH-VN, especially 
at the lower concentrations (Sano, K., et al. 2007). 
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Fig. 2. Changes in electrophoretic mobility and collagen-binding of rat vitronectin at 24 h 
after partial hepatectomy. (A) SDS-PAGE of vitronectins from non-operated rats (N), 
partially hepatectomized (PH) rats at 6-240h after operation, and sham-operated (SH) rats at 
24 h after operation. (B) Type I collagen (1 µg/100 µL) was coated onto wells of microtiter 
plates. After blocking with 5% BSA, various concentrations of purified vitronectins were 
added to each well. The bound vitronectin was measured using HRP-conjugated rabbit anti-
human vitronectin IgGs and ELISA. The absorbance of collagen-bound vitronectin was 
corrected for the antibody reactivity of each vitronectin. (C) Collagen was immobilized on a 
CM5 sensor chip, and each vitronectin in PBS was injected onto the sensor chip at a flow rate 
of 20 µL/min at 20°C. The change of resonance units (RU) was corrected by subtracting the 
value on the BSA-immobilized reference cell.  
2.1.2 Changes in glycosylation and carbohydrate concentration of vitronectin during 
early stage of liver regeneration 
As shown in Fig. 3, the carbohydrate analyses of the three vitronectins indicated that total 
carbohydrate contents of PH-VN and SH-VN decreased to one-third and one-half of that of 
NO-VN, respectively, and that a remarkable decrease in sialic acids and amounts of glycans 
occurred due to partial hepatectomy. The lectin reactivity of the three vitronectins indicated 
that these vitronectins contain complex-type N-linked oligosaccharides. The reactivity 
toward Phaseolus vulgaris lectin L4 (L-PHA) varied remarkably among vitronectins, and PH-
VN showed marked reactivity with L-PHA, but SH- and NO-VNs reacted only slightly, 
suggesting that tri- or tetraantennary lactosamine-branched structures multiplied 
dramatically after partial hepatectomy. The specificity of PVL toward clustered sialyl 
residues (Ueda, H., Kojima, K., et al. 1999) (Ueda, H., Matsumoto, H., et al. 2002), the 
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remarkably decreased reactivity of PH-VN with Psathyrella velutina lectin (PVL), together 
with the decrease in the reactivities with concanavalin A (Con A) and Lens culinaris lectin 
(LCA), indicate that the sialylated N-glycans markedly decreased after partial hepatectomy, 
which agrees well with the decreased amounts of carbohydrates including sialyl residues of 
the PH-VN. The changes in branching glycans would be attributable to the activity of 
several glycosyltransferases, which have been reported to increase (Miyoshi, E. , et al. 1995; 
Okamoto, Y., et al. 1978), while the decreased N-glycosylation of vitronectin at 24 h after 
partial hepatectomy could be attributed to the attenuation of the oligosaccharide transferase 
activity in microsomes (Oda-Tamai, S., et al. 1985).  
 
Fig. 3. The carbohydrate concentration, composition, and reactivity with lectins of 
vitronectins (VN) from non-operated (NO), sham-operated (SH), and partially 
hepatectomized (PH) rats. 
2.1.3 Mechanism of enhanced collagen binding by change of vitronectin glycosylation 
To study the enhancement of the mechanism for collagen binding, NO-VN was 
deglycosylated by sequential exoglycosidase treatments and collagen binding activity was 
analyzed by ELISA. As shown in Fig. 4A, collagen-binding of vitronectin gradually 
increased with step-wise trimming of glycans. Deglycosylated vitronectin (NG) showed 
collagen-binding activity three times higher than that of control vitronectin, suggesting that 
the enhancement of collagen binding of PH-VN is due to the changes in glycosylation (Sano, 
K., et al. 2007). 
The deglycosylated NO-VNs were analyzed for multimer formation by ultracentrifugation, 
and the multimer sizes were calculated from the weight average molecular weight of 
vitronectin (Fig. 4B). The multimer sizes were gradually increased by step-wise 
deglycosylation, accompanied with an increase of the amounts of multimer vitronectins, 
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which were cross-linked by disulfide-bonds, as measured by the intensity ratio of bands in 
SDS-PAGE before and after reduction, as shown in Fig. 4C. The enhanced collagen-binding 
activity of PH-VN was attributable to a multivalent effect that was due to the increase in 
the sizes and amounts of multimer vitronectins. The increase in multimer vitronectins in 
active form in various ligand-binding activities will accelerate the matrix incorporation of 
PH-VNs. 
 
Fig. 4. The collagen binding activities (A), molecular weight and multimerization (B), and 
relative amounts of multimer (white bar) to monomer (black bar) of glycan-trimmed human 
vitronectin. The typical complex-type glycan structures of mammalian vitronectin was 
sequentially trimmed by sialidase (S), β-galactosidase (G), β-hexosaminidase (H), and N-
glycosidase F (NG). U: untreated vitronectin; C: control vitronectin incubated without 
enzyme.  
2.1.4 Effects of glycosylation of vitronectin on hepatic stellate cell spreading 
Hepatic stellate cells are fibrotic cells that are induced during hepatic inflammation and are 
the major source of the newly synthesized ECM during hepatic fibrosis, whereas the 
survival or apoptosis of hepatic stellate cells is critical for the development or resolution, 
respectively, of liver fibrosis in chronic liver diseases (Benyon, R.C. and Arthur, M.J. 2001). 
In the normal liver, hepatic stellate cells have a low proliferation rate and produce trace 
amounts of ECM. As liver fibrosis progresses, hepatic stellate cells proliferate, but during 
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the resolution of fibrosis there is extensive apoptosis that coincides with degradation of the 
liver scar (Benyon, R.C. and Arthur, M.J. 2001). It was reported that the activation of hepatic 
stellate cells increased the expression of integrin ǂvǃ3, which is the major receptor of 
vitronectin on the cell surface, and promotes their proliferation and survival (Kato, S. and 
Akamatsu, N. 1985). We determined the structure and changes of rat vitronectin glycans 
during liver regeneration, and observed the relationship between the survival signaling of 
hepatic stellate cells and glycosylation of vitronectin. 
 
Fig. 5. Spreading and FAK-phosphorylation of HSCs on vitronectins. HSCs were plated on 
substrates coated with 10 μg/mL of vitronectins purified from NO, SH, or PH rats or 
desialylated (S) or de-N-glycosylated (NG) vitronectin. After 90-min incubation at 37°C in 
5% CO2, the % of the cells spread and FAK-phosphorylated were assessed by taking those 
on NO-VN as 1. Photomicrographs at ×40 magnification are shown on the upper panel. The 
data were analyzed by Student’s t-test. The data represent the means S.D. (n=6); ***, p<0.001; 
*, p<0.05 compared with that on NO-VN. 
In this study, vitronectins were purified from rat plasma at 24 hours after partial 
hepatectomy, sham-operation, or non-operated and designated as PH-, SH-, and NO-VN, 
respectively. The effect of PH-VN on HSC spreading was decreased to 1/2 of that of NO- or 
SH-VN (Fig. 5A). HSC spreading was also decreased on neuraminidase-treated vitronectin 
compared with untreated vitronectin, whereas it was decreased less on de-N-glycosylated 
NO-VN. These results indicate the importance of glycosylation, particularly sialylation, of 
vitronectin in HSC spreading. The effect of de-N-glycosylation was small compared with 
that of desialylation, because many sialic acid residues still remained on the O-glycans after 
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N-glycosidase F (PNGase F) treatment. In addition, PNGase F converts asparagine to 
aspartate, which may reduce the effect of the decrease of the negative charge of sialic acids. 
Because a clear difference between de-N-glycosylated and non-treated samples in cell 
spreading was still observed, suggesting the contribution of fibronectin-glycans to some 
extent, it cannot be concluded from this result that O-glycans contribute more to the 
decreased HSC spreading activity of PH-VN than N-glycans do.  
To address the effects of glycosylation of vitronectin on integrin-mediated signaling, the 
focal adhesion kinase (FAK) of HSCs was compared among NO-, SH-, and PH-VN. As 
shown in Fig. 5B, the amount of phosphorylated FAK on PH-VN was decreased in 
proportion to cell spreading. These results suggest that the change in vitronectin 
glycosylation due to partial hepatectomy is able to regulate activation of the integrin-
mediated signaling pathway. In addition, the effect of phosphorylated FAK on 
neuraminidase-treated NO-VN was decreased to an extent similar to that on PH-VN. 
2.1.5 Site-specific glycosylations of rat vitronectin 
In the early stage of liver regeneration, the synthesis of total DNA increased while the 
synthesis of total glycoproteins decreased within 48 h after partial hepatectomy (Okamoto, 
Y. and Akamatsu, N. 1977). The contradictory decrease of total glycoprotein synthesis in 
regenerating rat liver is due to the attenuation of oligosaccharide transferase activity in 
microsomes (Oda-Tamai, S., et al. 1985). Alterations in the glycan structure of total hepatic 
glycoproteins have been also suggested during liver regeneration (Kato, S. and Akamatsu, 
N. 1985; Ishii, I., et al. 1985). However, the changes in the glycans of a particular 
glycoprotein have not been well characterized. For these reasons, we investigated the site-
specific glycosylations and changes after partial hepatectomy in rat plasma vitronectin. 
Liquid chromatography/mass spectrometry analysis (LC/MSn) of Glu-C glycopeptides 
determined the site-specific glycosylation of each vitronectin. Four potential sites, Asn86, 
Asn96, Asn167, and Asn240 were revealed to be N-glycosylated, while the peptides of residues 
Thr110-Thr124 were O-glycosylated. The most frequent N-glycan structures site-specifically 
found for each site are shown in Fig. 6. At Asn86, Asn96, and Asn240, biantennary complex-
type trisialoglycans with or without core fucosylation and with different amounts of O-
acetylated NeuNAc were deduced (Fig. 6), whereas biantennary hybrid-type N-glycans 
were found to be the major structures at Asn167. In the Thr110–Thr124 region, the highly 
sialylated glycans were detected in the negative ion mode spectrum, and analysis in positive 
ion mode revealed that a Hex-HexNAc unit was located in the inner region of the glycans. 
From the results of lectin reactivity (18), it was inferred that one to three sialylated core-1 
type molecules were attached.  
These O-glycans contained disialic acid, which was chemically confirmed by fluorometric 
C7/C9 analyses and mild acid hydrolysate-fluorometric anion-exchange chromatography 
(Yasukawa, Z., Sato, C., et al. 2005). PH-VN had less disialyl O-glycans and complex-type N-
glycans, but more core-fucosylated N-glycans than NO-VN (Sano, K., et al. 2010).  
At the same time, alterations in the glycosylation of fibronectin (FN) after PH were different 
from those of vitronectin. The carbohydrate concentration of PH-FN decreased to 66% of 
that of NO- and SH-FNs. LC/MSn revealed that eight kinds of complex-type N-glycan 
structures were present in NO-, SH-, and PH-FNs, and that bi- and trisialobiantennary 
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glycans were the major structures (Sano, K., et al. 2008). Hybrid-type N-glycans and disialyl 
O-glycans were not detected. These results indicate that the alterations in the glycosylations 
of fibronectin and vitronectin were significantly different in the early stage of liver 
regeneration and demonstrate that these glycoproteins play different biological roles in the 
promotion of tissue remodeling processes. 
 
Fig. 6. Site-specific glycosylation of rat plasma vitronectin. The four glycosylation sites on 
rat plasma vitronectin and the glycan structures at each glycosylation site were determined 
by glycopeptide analyses using LC/MSn. The most frequent glycan structures that were 
present at each site are presented. 
2.1.6 Change in isoelectric points and oligosialylation of vitronectin 
Highly sialylated O-glycans, which have a diNeuAc structure and were markedly decreased 
in PH-VN, affect the isoelectric points of vitronectins. Immunostaining of vitronectins after 
two-dimensional PAGE showed that each vitronectin has two components, pI 4.0 and 5.7 in 
NO-VN, that both shifted to higher pI, pI 4.3 and 6.0 in SH-VN, and further to pI 4.6 and 6.0 
in PH-VN (Fig. 7). The pI of NO-VN was converted to one basic point, pI 6, after 
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neuraminidase treatment, and only the more acidic component of pI 4.1 reacted with mAb 
S2–566, which specifically recognizes the Neu5Acǂ2,8Neu5Acǂ2,3Gal structure (Yasukawa, 
Z., et al. 2006). 
 
Fig. 7. Two-dimensional PAGE and western blotting of vitronectins. The first electrophoresis 
was isoelectric focusing. The second electrophoresis was SDS-PAGE under reducing 
conditions on 7.5% polyacrylamide gel, followed by blotting onto a polyvinylidene 
difluoride membrane and immunostaining using sheep anti-vitronectin IgGs (A–D) or the 
anti-oligosialic acid monoclonal antibody S2–566 (E), and HRP-conjugated secondary 
antibodies. Membranes were developed with ECL-Plus. 
The results were also supported by the immunodetection of each vitronectin after 2D-PAGE 
where both hyper- and hyposilalylated molecules were present and the hypersialylation in 
PH-VN was markedly attenuated (Fig. 3). These analyses showed that the oligosialic acid on 
the O-glycan significantly affected the pI of the acidic partially hepatectomized vitronectin 
fraction. In addition to the decrease of oligosialyl epitopes in PH-VN, undersialylation of 
both N- and O-glycans was found in the basic PH-VN fraction. 
The presence of disialic acid structures in some glycoproteins was previously described 
(Finne, J., et al. 1977), and neural cell adhesion molecules have been very thoroughly studied 
(Finne, J., Krusius, T., et al. 1977). Changes in expression of the oligosialic epitope on serum 
glycoproteins under inflammatory conditions were also reported (Yasukawa, Z., et al. 2005) 
(Yasukawa, Z., et al. 2007). The fact that the amounts of disialic acid structures in PH-VN 
were decreased compared with those in NO-VN indicates that the inflammation caused by 
partial hepatectomy reduces disialylation on vitronectin. The results indicate that the 
decreased sialylation plays a key role in regulating the function of vitronectin in liver 
regeneration. 
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In contrast to PH-VN, the glycosylation and biological activities of vitronectin in cirrhotic 
plasma were differentially changed. Yamada’s group reported that vitronectin, which is 
active in collagen-binding in plasma, increased and correlated with certain fibrous markers 
(Yamada, S., et al. 1997, Yamada, S., et al. 1996), that the concentration of vitronectin in liver 
tissue was significantly increased in chronic liver disease compared with that in normal 
controls, and that vitronectin was colocalized at fibrous sites (Kobayashi, J., et al. 1994). 
Several reports supported the observation; therefore, the immunoreactivity of vitronectin in 
liver can be considered a marker of chronic/mature fibrosis. The vitronectins in untreated 
plasma exist mainly in native inactive form and exhibit low collagen binding. Urea 
treatment of cirrhotic and normal plasma revealed that the ratio of active to inactive 
vitronectin in cirrhotic plasma increased to more than twice that in normal plasma, 
promoting the incorporation of vitronectin from plasma into the matrix proceeds in spite of 
the fact that the vitronectin concentration in cirrhotic plasma was only 70% of that in normal 
plasma (Suzuki, R., et al. 2001). It is important to elucidate the changes in the glycosylation 
and biological activities of vitronectin in cirrhotic plasma and compare them with those of 
liver regeneration. 
2.2 Summary  
The present study attempted to determine how alterations of glycans modulate the 
biological activities of vitronectin during the initial stage of liver regeneration. Plasma 
vitronectin was purified from partially hepatectomized and sham-operated rats at 24 hours 
after operation and from non-operated rats. We found that the glycosylation of vitronectin 
changed and decreased markedly after surgery. The multimer sizes of PH- and SH-VNs 
significantly increased compared with NO-VN, and the change was accompanied by an 
increase in collagen binding. It was indicated that these changes were due to the changes in 
glycosylation of vitronectin, especially decreased sialylation, which increased the size and 
amount of the multimers to enhance the collagen-binding activity by a multivalent effect. 
Adhesion and spreading of rat hepatic stellate cells on PH-VN was decreased to 1/2 of that 
on NO- or SH-VN. Similarly, desialylated NO-VN decreased the spreading of rat hepatic 
stellate cells to 1/2 of that of control vitronectin, indicating the importance of sialylation of 
vitronectin for activation of rat hepatic stellate cells. LC/MSn of vitronectin glycopeptides 
determined the site-specific glycosylation and the presence of highly sialylated O-glycans, 
which dramatically decreased after partial hepatectomy. Understanding the functional 
modulation of glycans on vitronectin may contribute to development of a strategy to 
regulate liver regeneration and matrix fibrosis in liver cirrhosis. 
3. New method to detect changes in sialylation 
As described in the previous sections, in the initial stage of the liver regeneration, alterations 
in sialylation of vitronectin modulate the important biological activities of vitronectin 
during tissue-remodeling processes by multiple steps. Like vitronectin, the sialylation of 
other glycoproteins changes under pathological conditions as well as during developmental 
stages, and altered sialylation often has significant implications in the physiological role of 
glycoproteins (Varki, A., Commings, R.D., Esko, J. D., Freeze, H. H.,Stanley, P., H., Bertozzi, 
C.R., Hart, G.W., Etzler, M.E. 2009)(Rutishauser, U. 1998). The aim of this section is to 
describe a fundamental method using chromatofocusing that enables detection of the 
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changes in sialylation and separation of the matrix glycoproteins according to their pI in 
small amounts. The strategy is technically feasible and is applicable to various glycoproteins 
for a number of biological systems.  
3.1.1 Principle of chromatofocusing 
Chromatofocusing was originally a method of purification by separating proteins according 
to their pI. The pI of a protein is the pH at which the protein has zero surface charge. If a 
buffer, initially adjusted to the first pH, is run through an ion exchange column (see Fig. 8A) 
and followed by another buffer of a second pH, a pH gradient is formed in the column (Fig. 
8B) (Sluyterman, L.A.A. E., O 1978; Sluyterman, L.A. and Wijdenes, J. 1978). If this pH 
gradient is used to elute proteins bound to the ion exchanger, the proteins in the column are 
eluted in the order of their pI. If the pH of the mobile phase around a protein is higher than 
the protein’s pI, the protein has a positive charge. Therefore, it is dissociated from the anion 
exchange column and eluted from the column (Fig. 8A-C). If the pH of the mobile phase is 
lower, the protein has a negative charge and remains in the column (Shan, L. and Anderson, 
D.J. 2001). In this study, we applied chromatofocusing to detect the changes in sialylation of 
glycoproteins during liver degeneration. 
 
Fig. 8. Proteins having different pI are separated from each other as they pass through the 
anion exchanger column. A sample containing proteins that are  (pI = 7.0),  (pI = 5.5), 
and  (pI = 4.0) was applied to the column. (A) When the first buffer (pH 7.0) was poured 
into the column, the pH in the column is 7.0; therefore, rectangle proteins (pI >7.0) are 
eluted. Triangle and hexagon proteins (pI<7.0) are still bound to the column because they 
are negatively charged at pH 7.0. (B), When the second buffer (pH 4.0) was added, the pH in 
the column becomes lower, and this is halfway through the elution. (C), When the second 
buffer (pH 4.0) was continuously loaded, the pH in the column became pH 4.0 throughout 
the column, and then the hexagon proteins (pI=4.0) were eluted at the end of the elution. 
3.1.2 Method 
Rat plasma samples were collected at 24 h, 48 h, 72 h, 5 d, or 7 d after two-thirds 
hepatectomy or sham operation and stored at -80°C until use. Each plasma sample (200 
µg/100 µl) was applied to chromatofocusing using a Mono P5/50 GL column (GE 
www.intechopen.com
 
Liver Regeneration 92
Healthcare Inc.) and a fast protein liquid chromatograph (FPLC; AKTA Purifier, GE 
Healthcare, Inc). The starting buffer was 0.025 M bis-Tris, pH 7.1, and the elution buffer was 
10% Polybuffer74, pH 4.0. Buffers were filtered through 0.22 µm filters under vacuum and 
degassed. Samples were adjusted to the pH of the starting buffer, or exchanged by dialysis 
into the starting buffer. The column was pre-equilibrated with the starting buffer until the 
eluent was applied to the column, which was the same pH as that of starting buffer. After 
samples were applied to FPLC, the elution buffer was added. Samples were separated by 
the pI of each component protein in the column, and sequentially eluted from the column. 
The effluent was continuously monitored by absorbance at 280 nm and divided by 1 
mL/tube. After the pH gradient ended, the column was washed with two column volumes 
of 2M NaCl to elute the molecules still bound to the column. Finally, the column was re-
equilibrated with five column volumes of starting buffer until UV absorbance and pH 
values reached a plateau. An aliquot (10 µL) of each fraction eluted from the column was 
subjected to SDS-PAGE on a 7% polyacrylamide gel, and the separated protein bands were 
electro transferred to a polyvinylidene difluoride membrane and detected with specific 
antibodies to vitronectin. Membranes were developed with ECL (GE Healthcare Inc.). 
3.1.3 Results 
An example of the elution pattern of rat plasma is shown in Fig. 9. As the buffer flowed 
through the chromatofocusing column, the pH decreased and a descending pH gradient 
was generated. As shown in Fig. 10, when vitronectin in rat plasma was separated by 
chromatofocusing, NO-VN was eluted at pH 4.7–4.5, while PH–VN (24 h) was eluted at pH 
5.2-4.8. 
 
Fig. 9. Chromatogram of non-operated rat plasma. Dotted line, pH; solid line, absorbance 
at 280 nm. Flow rate: 0.5 mL/min, temperature: 4°C. Other conditions are described in the 
text. 
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Rat plasma vitronectin at 24 h after partial hepatectomy was shifted to a higher pI than that 
of NO-VN on two-dimensional PAGE, as shown in Fig. 7. The result of chromatofocusing 
combined with immunodetection suggests that sialylation of vitronectin remained low with 
pI over pH 5 for the period from 24 to 72h after partial hepatectomy. The pI of PH-VN after 
7d had recovered to pH 4.7–4.5 (data not shown). 
 
Fig. 10. The elution pattern of vitronectin with descending elution pH. The amount of 
vitronectin was measured by the band intensity of an immunoblot of the eluted fraction and 
is expressed as %, when taking that of 1 µg of purified NO-VN as 100%. Solid line: PH-VN 
(24 h), chain line: NO-VN, dotted line: pH of the eluted fraction. 
3.1.4 Discussion 
The elution pattern on chromatofocusing was very reproducible, and the pIs of NO-VN and 
PH-VN were found to be 4.7–4.5 and 5.2–4.8, respectively (Fig. 10). The immunostaining of 
PH-VN after two-dimensional PAGE (Fig. 7) indicated the presence of two components (pI 4.6 
and 6.0), whereas PH-VN was eluted by chromatofocusing at intermediate pH, although the 
two methods agreed on the tendency for the pI of PH-VN to be considerably shifted toward 
alkalinity compared to that of NO-VN. This discrepancy may be due not only to the difference 
in the plasma sample lots but also because parts of the vitronectin eluted by chromatofocusing 
are multimerized in the buffer like the vitronectin in physiological plasma, which shows a 
broad pH range of elution peaks indicating variation in sialylation of the vitronectin molecules 
contained. Chromatofocusing has the advantage of analyzing the isoelectric property under 
physiological conditions, especially in detection of changes in sialylation of glycoproteins, and 
the eluted fractions are utilizable for activity measurements (Kneba, M., et al. 1983). 
3.1.5 Summary 
Each plasma sample was subjected to chromatofocusing using FPLC, which can separate 
molecules by their isoelectric point (pI). Fractions eluted from the column were subjected to 
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SDS-PAGE, electrotransferred to a PVDF membrane, and detected with specific antibodies 
to vitronectin or fibronectin.  
Key results: The chromatofocusing and immunoblotting of plasma before and after sialidase 
treatment enabled us to demonstrate when and what alteration of sialylation occurs in each 
glycoprotein at each different stage during liver regeneration. The changes in pI essentially 
coincided with that of 2D-PAGE; however, we can determine the pI of a sample under 
physiological condition by using the chromatofocusing technique. Furthermore, this method 
is facile, quick, and applicable to recovered samples for activity analyses because they are 
non-denatured and separated by pI. 
4. Conclusion  
This study proposes that alterations of glycosylation, especially decreased sialylation of 
vitronectin, modulate tissue remodeling processes in multiple steps, especially HSC 
spreading and survival. Our findings suggest that the removal of sialic acid from vitronectin 
suppressed activation of stellate cells, indicating the possibility of a new treatment for or 
method to prevent liver cirrhosis. This will open new windows to the paradigm of glyco-
regenerative medicine, which is based on the modulatory functions of glycans of ECM 
glycoproteins such as vitronectin. 
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